vs
Side-by-side financial comparison of Avidia Bancorp, Inc. (AVBC) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $26.8M, roughly 1.4× Avidia Bancorp, Inc.). Avidia Bancorp, Inc. runs the higher net margin — 22.9% vs -161.8%, a 184.7% gap on every dollar of revenue. Avidia Bancorp, Inc. produced more free cash flow last quarter ($24.1M vs $-71.3M).
Avidia Bank is an American mutual community bank headquartered in Hudson, Massachusetts. It was founded in 2007 when it was formed by a merger between Hudson Savings Bank and Westborough Bank.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
AVBC vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.8M | $38.3M |
| Net Profit | $5.3M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | 33.3% | -169.0% |
| Net Margin | 22.9% | -161.8% |
| Revenue YoY | — | 407.0% |
| Net Profit YoY | — | -4.7% |
| EPS (diluted) | — | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.8M | $38.3M | ||
| Q3 25 | $28.0M | $32.1M | ||
| Q2 25 | $25.9M | $26.4M | ||
| Q1 25 | $22.9M | $16.5M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | — | $6.1M |
| Q4 25 | $5.3M | $-61.9M | ||
| Q3 25 | $-907.0K | $-67.3M | ||
| Q2 25 | $3.9M | $-92.6M | ||
| Q1 25 | $-11.6M | $-129.6M | ||
| Q4 24 | — | $-59.2M | ||
| Q3 24 | — | $-85.7M |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — |
| Q4 25 | 33.3% | -169.0% | ||
| Q3 25 | -7.0% | -173.5% | ||
| Q2 25 | 19.4% | -269.8% | ||
| Q1 25 | -72.0% | -390.1% | ||
| Q4 24 | — | -919.0% | ||
| Q3 24 | — | -1314.3% |
| Q4 25 | 22.9% | -161.8% | ||
| Q3 25 | -3.2% | -209.8% | ||
| Q2 25 | 15.0% | -350.3% | ||
| Q1 25 | -50.5% | -784.9% | ||
| Q4 24 | — | -783.4% | ||
| Q3 24 | — | -1404.0% |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | $-0.05 | $-0.07 | ||
| Q2 25 | — | $-0.10 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | — | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $275.0M | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $379.0M | $-500.5M |
| Total Assets | $2.8B | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $275.0M | $242.8M | ||
| Q3 25 | $208.3M | $257.8M | ||
| Q2 25 | $592.5M | $153.7M | ||
| Q1 25 | — | $61.6M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $130.4M |
| Q4 25 | $379.0M | $-500.5M | ||
| Q3 25 | $372.0M | $-524.3M | ||
| Q2 25 | $191.4M | $-570.7M | ||
| Q1 25 | $186.1M | $-591.4M | ||
| Q4 24 | — | $-489.1M | ||
| Q3 24 | — | $-745.1M |
| Q4 25 | $2.8B | $501.9M | ||
| Q3 25 | $2.8B | $519.0M | ||
| Q2 25 | $3.0B | $402.1M | ||
| Q1 25 | $2.7B | $303.8M | ||
| Q4 24 | — | $382.9M | ||
| Q3 24 | — | $364.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.4M | $-70.4M |
| Free Cash FlowOCF − Capex | $24.1M | $-71.3M |
| FCF MarginFCF / Revenue | 89.9% | -186.2% |
| Capex IntensityCapex / Revenue | 16.0% | 2.4% |
| Cash ConversionOCF / Net Profit | 5.32× | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.2M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.4M | $-70.4M | ||
| Q3 25 | $24.1M | $-68.9M | ||
| Q2 25 | $-2.3M | $-79.7M | ||
| Q1 25 | $-2.2M | $-85.9M | ||
| Q4 24 | — | $-85.1M | ||
| Q3 24 | — | $-98.8M |
| Q4 25 | $24.1M | $-71.3M | ||
| Q3 25 | $23.3M | $-69.6M | ||
| Q2 25 | $-3.3M | $-80.8M | ||
| Q1 25 | $-3.9M | $-87.0M | ||
| Q4 24 | — | $-87.3M | ||
| Q3 24 | — | $-101.6M |
| Q4 25 | 89.9% | -186.2% | ||
| Q3 25 | 83.2% | -217.2% | ||
| Q2 25 | -12.8% | -305.9% | ||
| Q1 25 | -16.9% | -526.9% | ||
| Q4 24 | — | -1155.4% | ||
| Q3 24 | — | -1663.2% |
| Q4 25 | 16.0% | 2.4% | ||
| Q3 25 | 3.1% | 2.3% | ||
| Q2 25 | 3.7% | 4.1% | ||
| Q1 25 | 7.2% | 6.8% | ||
| Q4 24 | — | 28.0% | ||
| Q3 24 | — | 45.7% |
| Q4 25 | 5.32× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.60× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
